[1]
|
MOHW (2018) Cancer Prevention. https://health99hpagovtw/Box2/Cancer/newsaspx
|
[2]
|
Tokuda, Y., Yanagawa, M., Minamitani, K., Naoi, Y., Noguchi, S. and Tomiyama, N. (2020) Radiogenomics of Magnetic Resonance Imaging and a New Multi-Gene Classifier for Predicting Recurrence Prognosis in Estrogen Receptor-Positive Breast Cancer: A Preliminary Study. Medicine, 99, e19664. https://doi.org/10.1097/MD.0000000000019664
|
[3]
|
Ou, Q., Cheng, J., Zhang, L., Wang, H., Wang, W. and Ma, Y. (2017) The Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Breast Cancer: Deleterious or Advantageous? Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, 39, 1010428317706214. https://doi.org/10.1177/1010428317706214
|
[4]
|
Proctor, M.J., McMillan, D.C., Morrison, D.S., Fletcher, C.D., Horgan, P.G. and Clarke, S.J. (2012) A Derived Neutrophil to Lymphocyte Ratio Predicts Survival in Patients with Cancer. British Journal of Cancer, 107, 695-699. https://doi.org/10.1038/bjc.2012.292
|
[5]
|
Coussens, L.M. and Werb, Z. (2002) Inflammation and Cancer. Nature, 420, 860-867. https://doi.org/10.1038/nature01322
|
[6]
|
Mantovani, A., Savino, B., Locati, M., Zammataro, L., Allavena, P. and Bonecchi, R. (2010) The Chemokine System in Cancer Biology and Therapy. Cytokine & Growth Factor Reviews, 21, 27-39. https://doi.org/10.1016/j.cytogfr.2009.11.007
|
[7]
|
Rollins, B.J. (2006) Inflammatory Chemokines in Cancer Growth and Progression. European Journal of Cancer (Oxford, England: 1990), 42, 760-767. https://doi.org/10.1016/j.ejca.2006.01.002
|
[8]
|
Ludlam, C.A. (1980) The Assessment of Platelet Function in Vivo by Measurement of Beta-Thromboglobulin, Platelet Factor 4 and Platelet Survival. Artery, 8, 470-474.
|
[9]
|
Dubernard, V., Arbeille, B.B., Lemesle, M.B. and Legrand, C. (1997) Evidence for an Alpha-Granular Pool of the Cytoskeletal Protein Alpha-Actinin in Human Platelets That Redistributes with the Adhesive Glycoprotein Thrombospondin-1 during the Exocytotic Process. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 2293-2305. https://doi.org/10.1161/01.ATV.17.10.2293
|
[10]
|
Green, D.L. and Karpatkin, S. (2009) Effect of Cancer on Platelets. Cancer Treatment and Research, 148, 17-30. https://doi.org/10.1007/978-0-387-79962-9_2
|
[11]
|
Yang, H.J., Guo, Z., Yang, Y.T., Jiang, J.H., Qi, Y.P., Li, J.J., et al. (2016) Blood Neutrophil-Lymphocyte Ratio Predicts Survival after Hepatectomy for Hepatocellular Carcinoma: A Propensity Score-Based Analysis. World Journal of Gastroenterology, 22, 5088-5095. https://doi.org/10.3748/wjg.v22.i21.5088
|
[12]
|
Rashtak, S., Ruan, X., Druliner, B.R., Liu, H., Therneau, T., Mouchli, M., et al. (2017) Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer. Clinical Colorectal Cancer, 16, 115-123e3. https://doi.org/10.1016/j.clcc.2017.01.008
|
[13]
|
Graziano, V., Grassadonia, A., Iezzi, L., Vici, P., Pizzuti, L., Barba, M., et al. (2019) Combination of Peripheral Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lym- phocyte Ratio Is Predictive of Pathological Complete Response after Neoadjuvant Chemotherapy in Breast Cancer Patients. Breast (Edinburgh, Scotland), 44, 33-38. https://doi.org/10.1016/j.breast.2018.12.014
|
[14]
|
Deng, M., Ma, X., Liang, X., Zhu, C. and Wang, M. (2017) Are Pretreatment Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Useful in Predicting the Outcomes of Patients with Small-Cell Lung Cancer? Oncotarget, 8, 37200-37207. https://doi.org/10.18632/oncotarget.16553
|
[15]
|
Tas, M., Yavuz, A., Ak, M. and Ozcelik, B. (2019) Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Discriminating Precancerous Pathologies from Cervical Cancer. Journal of Oncology, 2019, Article ID: 2476082. https://doi.org/10.1155/2019/2476082
|
[16]
|
Proctor, M.J., Morrison, D.S., Talwar, D., Balmer, S.M., Fletcher, C.D., O’Reilly, D.S., et al. (2011) A Comparison of Inflammation-Based Prognostic Scores in Patients with Cancer. A Glasgow Inflammation Outcome Study. European Journal of Cancer (Oxford, England: 1990), 47, 2633-2641. https://doi.org/10.1016/j.ejca.2011.03.028
|
[17]
|
Ramos-Esquivel, A., Rodriguez-Porras, L. and Porras, J. (2017) Neutrophil-Lym- phocyte Ratio and Platelet-Lymphocyte Ratio as Prognostic Factors in Non-Meta- static Breast Cancer Patients from a Hispanic Population. Breast Disease, 37, 1-6. https://doi.org/10.3233/BD-160251
|
[18]
|
Fujii, T., Yanai, K., Tokuda, S., Nakazawa, Y., Kurozumi, S., Obayashi, S., et al. (2018) Relationship between FDG Uptake and Neutrophil/Lymphocyte Ratio in Patients with Invasive Ductal Breast Cancer. Anticancer Research, 38, 4927-4931. https://doi.org/10.21873/anticanres.12809
|
[19]
|
Fujimoto, Y., Ozawa, H., Higuchi, T., Miyagawa, Y., Bun, A., Imamura, M., et al. (2019) Improved Prognosis of Low Baseline Neutrophil-to-Lymphocyte Ratio Is Significantly Exclusive in Breast Cancer Patients with High Absolute Counts of Lymphocytes. Molecular and Clinical Oncology, 10, 275-284. https://doi.org/10.3892/mco.2018.1783
|
[20]
|
Dolan, R., Laird, B., Horgan, P. and McMillan, D. (2018) The Prognostic Value of the Systemic Inflammatory Response in Randomised Clinical Trials in Cancer: A Systematic Review. Critical Reviews in Oncology/Hematology, 132, 130-137. https://doi.org/10.1016/j.critrevonc.2018.09.016
|
[21]
|
Jia, W., Wu, J., Jia, H., Yang, Y., Zhang, X., Chen, K., et al. (2015) The Peripheral Blood Neutrophil-to-Lymphocyte Ratio Is Superior to the Lymphocyte-to-Mono- cyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients. PLoS ONE, 10, e0143061. https://doi.org/10.1371/journal.pone.0143061
|
[22]
|
Cho, U., Park, H.S., Im, S.Y., Yoo, C.Y., Jung, J.H., Suh, Y.J., et al. (2018) Prognostic Value of Systemic Inflammatory Markers and Development of a Nomogram in Breast Cancer. PLoS ONE, 13, e0200936. https://doi.org/10.1371/journal.pone.0200936
|
[23]
|
Nishijima, T.F., Deal, A.M., Lund, J.L., Nyrop, K.A., Muss, H.B. and Sanoff, H.K. (2019) Inflammatory Markers and Overall Survival in Older Adults with Cancer. Journal of Geriatric Oncology, 10, 279-284. https://doi.org/10.1016/j.jgo.2018.08.004
|
[24]
|
Coffelt, S.B., Wellenstein, M.D. and de Visser, K.E. (2016) Neutrophils in Cancer: Neutral No More. Nature Reviews Cancer, 16, 431-446. https://doi.org/10.1038/nrc.2016.52
|
[25]
|
Ocana, A., Nieto-Jiménez, C., Pandiella, A. and Templeton, A.J. (2017) Neutrophils in Cancer: Prognostic Role and Therapeutic Strategies. Molecular Cancer, 16, 137. https://doi.org/10.1186/s12943-017-0707-7
|
[26]
|
Swierczak, A., Mouchemore, K.A., Hamilton, J.A. and Anderson, R.L. (2015) Neutrophils: Important Contributors to Tumor Progression and Metastasis. Cancer and Metastasis Reviews, 34, 735-751. https://doi.org/10.1007/s10555-015-9594-9
|
[27]
|
Dumitru, C.A., Lang, S. and Brandau, S. (2013) Modulation of Neutrophil Granulocytes in the Tumor Microenvironment: Mechanisms and Consequences for Tumor Progression. Seminars in Cancer Biology, 23, 141-148. https://doi.org/10.1016/j.semcancer.2013.02.005
|
[28]
|
Spiegel, A., Brooks, M.W., Houshyar, S., Reinhardt, F., Ardolino, M., Fessler, E., et al. (2016) Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. Cancer Discovery, 6, 630-649. https://doi.org/10.1158/2159-8290.CD-15-1157
|
[29]
|
Zhao, W., Wang, P., Jia, H., Chen, M., Gu, X., Liu, M., et al. (2017) Lymphocyte Count or Percentage: Which Can Better Predict the Prognosis of Advanced Cancer Patients Following Palliative Care? BMC Cancer, 17, 514. https://doi.org/10.1186/s12885-017-3498-8
|
[30]
|
Liang, L., Zhu, J., Jia, H., Huang, L., Li, D., Li, Q., et al. (2016) Predictive Value of Pretreatment Lymphocyte Count in Stage II Colorectal Cancer and in High-Risk Patients Treated with Adjuvant Chemotherapy. Oncotarget, 7, 1014-1028. https://doi.org/10.18632/oncotarget.5835
|
[31]
|
Cho, O., Oh, Y.T., Chun, M., Noh, O.K. and Lee, H.W. (2016) Radiation-Related Lymphopenia as a New Prognostic Factor in Limited-Stage Small Cell Lung Cancer. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 971-978. https://doi.org/10.1007/s13277-015-3888-y
|
[32]
|
Tredan, O., Manuel, M., Clapisson, G., Bachelot, T., Chabaud, S., Bardin-dit- Courageot, C., et al. (2013) Patients with Metastatic Breast Cancer Leading to CD4+ T Cell Lymphopaenia Have Poor Outcome. European Journal of Cancer (Oxford, England: 1990), 49, 1673-1682. https://doi.org/10.1016/j.ejca.2012.11.028
|
[33]
|
Wild, A.T., Ye, X., Ellsworth, S.G., Smith, J.A., Narang, A.K., Garg, T., et al. (2015) The Association between Chemoradiation-Related Lymphopenia and Clinical Outcomes in Patients with Locally Advanced Pancreatic Adenocarcinoma. American Journal of Clinical Oncology, 38, 259-265. https://doi.org/10.1097/COC.0b013e3182940ff9
|
[34]
|
Li, C., Wen, T.-F., Yan, L.-N., Li, B., Yang, J.-Y., Xu, M.-Q., et al. (2013) Scoring Selection Criteria Including Total Tumour Volume and Pretransplant Percentage of Lymphocytes to Predict Recurrence of Hepatocellular Carcinoma after Liver Transplantation. PLoS ONE, 8, e72235. https://doi.org/10.1371/journal.pone.0072235
|
[35]
|
Asano, Y., Kashiwagi, S., Onoda, N., Noda, S., Kawajiri, H., Takashima, T., et al. (2016) Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer. Annals of Surgical Oncology, 23, 1104-1110. https://doi.org/10.1245/s10434-015-4934-0
|
[36]
|
Forget, P., Khalifa, C., Defour, J.-P., Latinne, D., Van Pel, M.-C. and De Kock, M. (2017) What Is the Normal Value of the Neutrophil-to-Lymphocyte Ratio? BMC Research Notes, 10, 12. https://doi.org/10.1186/s13104-016-2335-5
|
[37]
|
Hong, J., Mao, Y., Chen, X., Zhu, L., He, J., Chen, W., et al. (2016) Elevated Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Poor Disease-Free Survival in Chinese Women with Breast Cancer. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 4135-4142. https://doi.org/10.1007/s13277-015-4233-1
|
[38]
|
Kim, H.Y., Kim, T.H., Yoon, H.K. and Lee, A. (2019) The Role of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer. Journal of Breast Cancer, 22, 425-438. https://doi.org/10.4048/jbc.2019.22.e41
|
[39]
|
Xuan, Q., Yang, Y., Ji, H., Tang, S., Zhao, J., Shao, J., et al. (2019) Combination of the Preoperative Albumin to Globulin Ratio and Neutrophil to Lymphocyte Ratio as a Novel Prognostic Factor in Patients with Triple Negative Breast Cancer. Cancer Management and Research, 11, 5125-5131. https://doi.org/10.2147/CMAR.S195324
|
[40]
|
Hong, J., Chen, X., Gao, W., Zhu, S., Wu, J., Huang, O., et al. (2019) A High Absolute Lymphocyte Count Predicts a Poor Prognosis in HER-2-Positive Breast Cancer Patients Treated with Trastuzumab. Cancer Management and Research, 11, 3371-3379. https://doi.org/10.2147/CMAR.S187233
|
[41]
|
Menter, D.G., Tucker, S.C., Kopetz, S., Sood, A.K., Crissman, J.D. and Honn, K.V. (2014) Platelets and Cancer: A Casual or Causal Relationship: Revisited. Cancer and Metastasis Reviews, 33, 231-269. https://doi.org/10.1007/s10555-014-9498-0
|
[42]
|
Menter, D.G., Kopetz, S., Hawk, E., Sood, A.K., Loree, J.M., Gresele, P., et al. (2017) Platelet “First Responders” in Wound Response, Cancer, and Metastasis. Cancer and Metastasis Reviews, 36, 199-213. https://doi.org/10.1007/s10555-017-9682-0
|
[43]
|
Wojtukiewicz, M.Z., Sierko, E., Hempel, D., Tucker, S.C. and Honn, K.V. (2017) Platelets and Cancer Angiogenesis Nexus. Cancer and Metastasis Reviews, 36, 249-262. https://doi.org/10.1007/s10555-017-9673-1
|
[44]
|
Xu, X.R., Zhang, D., Oswald, B.E., Carrim, N., Wang, X., Hou, Y., et al. (2016) Platelets Are Versatile Cells: New Discoveries in Hemostasis, Thrombosis, Immune Responses, Tumor Metastasis and Beyond. Critical Reviews in Clinical Laboratory Sciences, 53, 409-430. https://doi.org/10.1080/10408363.2016.1200008
|
[45]
|
Li, B., Zhou, P., Liu, Y., Wei, H., Yang, X., Chen, T., et al. (2018) Platelet-to-Lymphocyte Ratio in Advanced Cancer: Review and Meta-Analysis. Clinica Chimica Acta; International Journal of Clinical Chemistry, 483, 48-56. https://doi.org/10.1016/j.cca.2018.04.023
|
[46]
|
De Giorgi, U., Mego, M., Scarpi, E., Giordano, A., Giuliano, M., Valero, V., et al. (2019) Association between Circulating Tumor Cells and Peripheral Blood Monocytes in Metastatic Breast Cancer. Therapeutic Advances in Medical Oncology, 11, 1758835919866065. https://doi.org/10.1177/1758835919866065
|
[47]
|
Cuello-Lopez, J., Fidalgo-Zapata, A., Lopez-Agudelo, L. and Vasquez-Trespalacios, E. (2018) Platelet-to-Lymphocyte Ratio as a Predictive Factor of Complete Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer. PLoS ONE, 13, e0207224. https://doi.org/10.1371/journal.pone.0207224
|
[48]
|
Bao, B. and Prasad, A.S. (2019) Targeting CSC in a Most Aggressive Subtype of Breast Cancer TNBC. Advances in Experimental Medicine and Biology, 1152, 311. https://doi.org/10.1007/978-3-030-20301-6_17
|
[49]
|
Ren, K., Yin, Y., He, F., Shao, Y. and Wang, S. (2018) Prognostic Role of Derived Neutrophil-to-Lymphocyte Ratio in Surgical Triple-Negative Breast Cancer. Cancer Management and Research, 10, 4891-4898. https://doi.org/10.2147/CMAR.S180695
|
[50]
|
Vernieri, C., Mennitto, A., Prisciandaro, M., Huber, V., Milano, M., Rinaldi, L., et al. (2018) The Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict Efficacy of Platinum-Based Chemotherapy in Patients with Metastatic Triple Negative Breast Cancer. Scientific Reports, 8, Article No. 8703. https://doi.org/10.1038/s41598-018-27075-z
|